藥用玻璃包裝市場規模、佔有率和成長分析（按材料、產品、藥物類型和地區）：產業預測（2024-2031）

2022年全球藥用玻璃包裝市場規模為180億美元，從2023年的199億美元成長到2031年的417億美元，複合年成長率預計將成長9.7%。

由於製藥業的擴張以及消費者對非反應性和可回收玻璃的偏好，藥用玻璃包裝市場正在經歷強勁成長。特別是在歐洲和西半球的已開發地區，為了實現永續的社會，玻璃的回收正在加速。隨著領先的物流公司投資創新解決方案以提高競爭力，技術進步正在塑造市場。同時，隨著製藥公司努力減少廢棄物和碳排放，向環保包裝的轉變正在加速。玻璃瓶完全可回收，是最環保的選擇。在印刷和標籤技術進步的推動下，客製化和個人化的興起進一步凸顯了該市場不斷發展的動態。

目錄

介紹

• 分析目的
• 市場範圍
• 定義

分析方法

• 資訊採購
• 次要/主要資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 市場概況及展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及前景

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考慮因素

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場魅力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 案例研究
• 專利分析
• 貿易分析

全球藥用玻璃包裝市場規模與複合年成長率：依材料分類（2024-2031）

• 市場概況
• Ⅰ型
• II型
• Ⅲ型

全球藥用玻璃包裝市場規模及複合年成長率：依產品分類（2024-2031）

• 市場概況
• 管瓶
  • 管瓶
  • 大管瓶
• 瓶子
• 藥筒和注射器
• 安瓿

全球藥用玻璃包裝市場規模及複合年成長率：按藥物類型分類（2024-2031）

• 市場概況
• 學名藥
• 品牌藥
• 生技藥品

全球藥用玻璃包裝市場規模及複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要企業採取的策略
• 近期市場趨勢
• 主要企業市場佔有率（2023年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• 格雷斯海默股份公司（德國）
• 康寧公司（美國）
• 尼普羅株式會社（日本）
• SGD SA (SGD Pharma)（法國）
• Stolzle-Oberglas GmbH（CAG Holding GmbH）（奧地利）
• Bormioli Pharma SpA（義大利）
• 西方製藥服務公司（美國）
• 肖特股份公司（德國）
• 山東藥用玻璃股份有限公司 (中國)
• 比森·克拉克（英國）
• 阿拉伯藥用玻璃公司（埃及）
• 皮拉馬爾玻璃私人有限公司（皮拉馬爾集團）（印度）
• Sisecam 集團（土耳其）
• 維拉利亞（法國）
• 山東藥維藥用玻璃有限公司 (中國)
• 浙江華創藥用玻璃有限公司 (中國)
• 常州華興藥用玻璃有限公司 (中國)
• 江蘇華興藥用玻璃有限公司 (中國)
• 江蘇凱迪藥用玻璃有限公司 (中國)
• 江蘇益康藥用玻璃有限公司 (中國)

結論和建議

Global Pharmaceutical Glass Packaging Market size was valued at USD 18 billion in 2022 and is poised to grow from USD 19.9 billion in 2023 to USD 41.7 billion by 2031, growing at a CAGR of 9.7% during the forecast period (2024-2031).

The pharmaceutical glass packaging market is experiencing robust growth driven by the expanding pharmaceutical sector and a consumer preference for glass due to its non-reactivity and recyclability. Glass recycling initiatives are escalating, especially in developed regions of Europe and the western hemisphere, spurred by a collective push for sustainable practices. Technological advancements are reshaping the market as major logistics companies invest in innovative solutions to enhance competitiveness. Meanwhile, the industry's shift towards eco-friendly packaging is accelerating as pharmaceutical companies strive to minimize waste and their carbon footprint. Glass jars stand out as the most environmentally friendly option, being completely recyclable. The rise in customization and personalization, fueled by advancements in printing and labeling technologies, further underscores the evolving dynamics in this market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Glass Packaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Glass Packaging Market Segmental Analysis

Global Pharmaceutical Glass Packaging Market is segmented by Material, Product, Drug Type and Region. Based on Material, the market is segmented into Type I, Type II, Type, III. Based on Product, the market is segmented into Vials, Bottles, Cartridges and Syringes, Ampoules. Based on Drug Type, the market is segmented into Generic, Branded, Biologic. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Glass Packaging Market

The increasing utilization of biologics, such as monoclonal antibodies and vaccines, is a significant catalyst for the growth of the global pharmaceutical glass packaging market. As the need for biologics rises, the demand for secure, sterile, and high-quality packaging intensifies, emphasizing the importance of glass vials and syringes in the healthcare industry. The effectiveness of these biologics relies on the integrity of their packaging, thus driving the market for pharmaceutical glass packaging further. This trend highlights the crucial role that glass packaging plays in the safe and efficient delivery of biologic therapies, ultimately boosting market expansion and development opportunities.

Restraints in the Global Pharmaceutical Glass Packaging Market

One of the significant challenges facing the global pharmaceutical glass packaging market is the increasing preference for alternative packaging materials, such as plastic and metal. These alternatives are often more affordable, lighter, and offer greater flexibility, making them appealing options for pharmaceutical companies seeking cost-effective solutions. As these materials continue to gain traction due to their practical advantages, they pose a notable restraint to the glass packaging sector. This shift in preference could potentially hinder the growth of the glass packaging market, as manufacturers and suppliers are compelled to adapt to changing demands and explore innovative packaging solutions.

Market Trends of the Global Pharmaceutical Glass Packaging Market

The Global Pharmaceutical Glass Packaging market is witnessing a significant trend driven by the surging demand for biologic drug packaging. As biologics, such as vaccines and monoclonal antibodies, gain prominence in therapeutics, the necessity for specialized glass packaging solutions is intensifying. Glass vials and syringes are becoming indispensable for ensuring a sterile and stable environment crucial for preserving the efficacy of these sensitive drugs. This shift towards advanced packaging solutions is fostering innovation in material design and manufacturing processes, thereby propelling market growth, catering to the stringent requirements of the pharmaceutical industry and enhancing patient safety.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Patent Analysis
• Trade Analysis

Pharmaceutical Glass Packaging Market Size by Material & CAGR (2024-2031)

• Market Overview
• Type I
• Type II
• Type III

Pharmaceutical Glass Packaging Market Size by Product & CAGR (2024-2031)

• Market Overview
• Vials
  • Small Vials
  • Large Vials
• Bottles
• Cartridges and Syringes
• Ampoules

Pharmaceutical Glass Packaging Market Size by Drug Type & CAGR (2024-2031)

• Market Overview
• Generic
• Branded
• Biologic

Pharmaceutical Glass Packaging Market Size & CAGR (2024-2031)

• North America (Material, Product, Drug Type)
  • US
  • Canada
• Europe (Material, Product, Drug Type)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Material, Product, Drug Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Material, Product, Drug Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, Product, Drug Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGD SA (SGD Pharma) (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stolzle-Oberglas GmbH (CAG Holding GmbH) (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bormioli Pharma S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schott AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Pharmaceutical Glass Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beatson Clark (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arab Pharmaceutical Glass Co. (Egypt)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Glass Private Limited (Piramal Group) (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sisecam Group (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verallia (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Yaowei Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhejiang Huachuang Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Changzhou Huaxing Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Huaxing Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Kaidi Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Yikang Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation